These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1084553)

  • 1. Antinuclear antibodies.
    Faber V; Feltkamp TE; Räsänen J
    Scand J Rheumatol Suppl; 1975; 12():121-2. PubMed ID: 1084553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 3. Antinuclear antibodies and disease specificity.
    Mongey AB; Hess EV
    Adv Intern Med; 1991; 36():151-69. PubMed ID: 2024580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies against soluble nuclear antigens in rheumatic diseases].
    Nikolov K; Baleva M
    Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a monoclonal and polyclonal anti-idiotype against a human IgG anti-DNA antibody.
    Ehrenstein MR; Hartley B; Wilkinson LS; Isenberg DA
    J Autoimmun; 1994 Jun; 7(3):349-67. PubMed ID: 7916908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
    Gripenberg M; Helve T; Kurki P
    J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The spectrum of antinuclear and anticytoplasmatic antibodies in collagenoses].
    Meurer M; Ring J
    Hautarzt; 1980 Sep; 31(9):478-85. PubMed ID: 6969717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNA.
    De Beéck KO; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Rheumatology (Oxford); 2012 Aug; 51(8):1515-6. PubMed ID: 22661555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies to denatured DNA detected by millipore filter assay in patients with SLE and other rheumatic diseases (author's transl)].
    Sarai T; Miyawaki S; Kurata N; Ofuji T
    Ryumachi; 1978 Sep; 18(5):335-43. PubMed ID: 310165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Difference in the positivity of antinuclear antibodies in pediatrics using rat kidney and human epithelial cells as a source of antigens].
    Arroyave CM; Arroyave ME
    Bol Med Hosp Infant Mex; 1986 Aug; 43(8):478-81. PubMed ID: 3530277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies and disease specificity].
    Ersöz US D
    Mikrobiyol Bul; 1992 Oct; 26(4):379-89. PubMed ID: 1435370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of antinuclear antibody fluorescence in leucocytes and hepatocytes.
    Monier JC; Thivolet J
    Rev Eur Etud Clin Biol; 1972; 17(6):582-91. PubMed ID: 4567345
    [No Abstract]   [Full Text] [Related]  

  • 14. The binding of anti-DNA antibodies as measured fluorometrically by ethidium bromide.
    Shepherd JD; Fritzler MJ; Watson JI; van de Sande JH
    J Rheumatol; 1978; 5(4):391-8. PubMed ID: 84077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of tests for antinuclear antibodies (ANA) in rheumatic diseases.
    Nakamura RN; Tan EM
    West J Med; 1978 Jan; 128(1):51-2. PubMed ID: 415436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of selected laboratory findings in rheumatic diseases. 2: The second step in diagnosis].
    Apostoloff E; Hiepe F; Mielke F
    Z Arztl Fortbild (Jena); 1987; 81(9):409-12. PubMed ID: 3498267
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests.
    Kavanaugh AF; Solomon DH;
    Arthritis Rheum; 2002 Oct; 47(5):546-55. PubMed ID: 12382306
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic specificity of anti-ROS DNA antibodies: involvement of lysyl residues in antigen binding.
    Ara J; Ali R
    Biochem Mol Biol Int; 1995 Jan; 35(1):213-22. PubMed ID: 7537571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.